Ella
Living with
ENPP1 Deficiency
One Pathway – Multiple Possibilities
We are dedicated to bringing health and hope to people with rare diseases linked to the PPi-Adenosine Pathway, which is crucial for maintaining healthy bones and blood vessels. Currently, there are no approved therapies for conditions like ENPP1 Deficiency, ABCC6 Deficiency, and calciphylaxis. Our team is working tirelessly to develop effective treatments for these patients and their families.
Clinical Trials
We are enrolling patients in clinical trials for a potential new treatment for ENPP1 Deficiency, ABCC6 Deficiency and calciphylaxis. With your participation, we can better understand these diseases and help inform possible future treatment options.
Patients & Families
Our dedication to those living with rare diseases goes beyond developing new treatments. We are committed to listening, educating, and providing comprehensive support. We aim to provide comprehensive resources and build strong relationships to truly support and empower patients and their families.
Healthcare Professionals
Your expertise and perspective are integral to the development of a potentially life-changing therapy. Learn more about our investigational therapy, ongoing clinical trials, support for genetic testing and connect with our team. Together, we can advance patient care and outcomes.